中文产业新闻精选评分80Chinese source
众生睿创RAY1225三期双周给药达主要终点，9mg组安慰剂校正减重20.46%
众生睿创：GLP-1R/GIPR激动剂III期研究成功
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
众生睿创：GLP-1R/GIPR激动剂III期研究成功
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.